1 / 68

Antidysrhythmic and Antihypertensive Agents

Antidysrhythmic and Antihypertensive Agents. NURS 1950 Pharmacology Nancy Pares, RN, MSN. Objective 1: Define the term ‘ectopic site’. Heart beat arises outside the sinoatrial (SA) node Terms: Inotropic Chromotropic Domotropic. Objective 2: Define the terms. Arrhythmia or dysrhythmia

dom
Télécharger la présentation

Antidysrhythmic and Antihypertensive Agents

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Antidysrhythmic and Antihypertensive Agents NURS 1950 Pharmacology Nancy Pares, RN, MSN

  2. Objective 1: Define the term ‘ectopic site’. • Heart beat arises outside the sinoatrial (SA) node • Terms: • Inotropic • Chromotropic • Domotropic

  3. Objective 2: Define the terms • Arrhythmia or dysrhythmia • Variation of normal rhythm-usually associated with cardiac • An electrical activity initiated by a spontaneous discharge

  4. Objective 3: Describe the actions of the antiarrhythmic drugs • Decrease the automaticity of the cardiac tissues distant from the sinoatrial node. • Alter the rate of conduction thru the heart • Alter the refractory period between consecutive contractions.

  5. Actions: Antiarrhythmic agents • Classed according to action • Class I: myocardial depressents-inhibit sodium ion movement preventing depolorization • Ia: prolongs electrical stimulation (in cell) prolongs refractory time between impulses –delays repolarization Ib: shortens the duration of the e-stimulation and the time between impulses—accelerates repolerization Ic: most potent-slows conduction rate through atria and ventricles—no effect on repolorization

  6. Antirrhythmics: Actions Class II: beta-andrenergic blocking agents -block sympathetic stimulation (slows conduction and decreases HR Class III: slows the rate of electrical conduction and prolongs refractory time -potassium channel blocking

  7. Antirrhythmic class actions Class IV:blocks calcium ion flow-prolongs elec stimulation and slows AV node conduction Misc: Adenosine and Digoxin: not related to any other agents

  8. Objective 4: Identify actions, results and uses of major antirrhythmics • Objective 5: List the side effects of antirrhythmics

  9. Class Ia: Sodium channel blockers • Includes: • Disopramide phosphate (Norpace) • Procainamide HCL (Pronestyl) • Quinidine gluconate (Duraquin) • Quinidine polygluconate (Cardioquin) • Prototype: Procainamide (Pronestyl)

  10. Quinidine (Quinidex, Duratab) • -derived from the cinchona bark • -cardiac depressant effects: reduces excitability of the cardiac muscle, prolongs refractory period between consecutive contractions • Allows the sinoatrial node to take over

  11. Quinidine • Used for atrial tachycardia, flutter and fibrillation. • Side effects severe: 1/3 of clients must d/c use

  12. Quinidine • S/E: • GI distress • CV disorders • Rashes, respiratory arrest, hemolytic anemia, agranulocytosis • Hypersensitivity • Cinchonism: tinnitus, nausea, HA, dizziness impaired vision, vertigo

  13. Quinidine • Nursing Implications: • Can reduce problems if nurse: • Avoid use in CHF patients • Monitor digitalis levels (if on digitalis) • Monitor potossium (K+) levels • Monitor sodium (Na+) levels

  14. Quinidine • Routes: • Oral with meals • Parenteral: give slowly

  15. Procainamide (Pronestyl, Procan SR) (Ia) • Uses:ventricular arrhythmias (best), atrial fibrillation(helpful), paroxysmal atrial tachycardia (PAT) • S/E: GI distress, ventricular tachy, hypotension and hypersensitivity • Allergy most likely if allergic to ‘caine’ drugs (related to local anesthetics) • Can cause agranulocytosis: lupus like syndrome

  16. Disopyramide (Norpace, Rythmodan) • S/E: hypotension, tachyarrythmias, anticholinergic effects • Has lower incidence of adverse effects than quinidine or procainamide • Oral dosing

  17. Class Ib: Sodium (Na+)Channel Blockers • Lidocaine (Xylocaine) • Mexiletine (Mexitil) • Phenytoin (Dilantin) • Tocainide (Tonocard)

  18. Lidocaine (Xylocaine, Xylocard) • Use:Preventricular contractions (PVC), cardiac glycoside-induced tachyarrhythmias, cardioversion • Action: very rapid onset (IV), short acting • Shortens the duration of elec stim • Gives precise control of cardiac status

  19. Lidocaine (Xylocaine, Xylocard) • S/E/Route: • Excessive decrease in cardiac electrical conductivity • Hypotension, bradycardia, dizziness; CNS effects • Hypermetabolism (malignant hyperthermia • ineffective if given orally (metabolized in liver)

  20. Lidocaine (Xylocaine, Xylocard) • Nursing Interventions: • Continuous EKG • Look at bottle before giving-should not contain preservatives or epinephrine

  21. Phenytoin (Dilantin) (Ib) -standard classification is neuroleptic, but used for arrythmias caused by cardiac glycoside intoxication Action: decreases automaticity of cardiac muscle, increases rate of conduction of the cardiac electrical impulses

  22. Phenytoin (Dilantin) • S/E/ Route: • Neurological disturbances: peripheral neuropathy, diplopia, ataxia, vertigo, drowsiness, confusion • GI disturbances • Skin rash

  23. Tocainide (Tonocard)(Ib) • Similar to lidocaine • Nursing Interventions: • Given orally only • Monitor EKG • Client teaching: s/e and when to call MD • S/E: • Dizziness, nausea, parethesia, numbness, restlessness, tremor, GI distress, blood dyscrasias • Should not be used in 2nd or 3rd degree AV block without a pacemaker

  24. Mexiletine HCL (Mexitil) • Action: similar to lidocaine • Use: ventricular arrhythmias • S/E/route: • N/V, heartburn, dizziness, tremor, impaired coordination • Given orally

  25. Class IC: Sodium(Na+) Channel blockers • Flecainide (Tambocor) • Encainide (Enkaid) • Rythmol

  26. Flecainide acetate (Tambocor)Encainide HCL (Enkaid) • Action: local anesthetic • Use: ventricular arrhythmias • S/E/route: • Can cause new or worsen arrhythmias • High degree of negative inotropy • Dizziness, visual disturbances, HA, nausea, fatigue, chest pain

  27. Propafenone HCL (Rythmol) • Local anesthetic, membrane stabalizing, some beta blocking effect • Use: life threatening ventricular arrhythmias • S/E: may cause new or worsen existing arrhythmias, dizziness, GI disturbances, may see 1st degree AV block • Nursing Interventions: monitor with EKG • Contraindications: uncontrolled CHF, brady, bronchospasm, severe hypotension

  28. Class II: Beta adrenergic blocking agents • Acebutolol (Sectral) • Esmolol (Brevibloc) • Propranolol (Inderal) • Action: • Inhibits cardiac response to sympathetic nerve stimulation by blocking the beta receptors; reduces heart rate, systolic BP and cardiac output.

  29. Class II: Beta adrenergic blocking agents • Use: • Ventricular arrhythmias • Sinus tachycardia • Paroxysmal atrial tachycardia (PAT) • Premature ventricular contractions (PVC) • Tachycardia associated with atrial flutter,or fibrillation

  30. Class II: Beta adrenergic blocking agents • S/E: • What would we expect to see? • Slow HR, orthostatic hypotension, SOB, painful urination, wt gain > 2 lbs/day, insomnia, drowsiness, confusion • Mask the signs of hypoglycemia • Nursing Interventions: • Take pulse and report below 50, rise slowly, report symptoms, diabetics monitor BS closely

  31. Class III: Potassium(K+)channel blockers • Amiodarone (Cordarone) • Dofetilidide (Tikosyn) • Sotalol (Betaspace)

  32. Amiodarone hydrochloride (Cordarone) • Action: • Prolongs the action potential of the atrial and ventricular tissues • Antagonizes (non competitive) the alpha and beta receptors causing vasodilation • Use: • Life threatening arrythmias non responsive to other agents

  33. Amiodarone hydrochloride (Cordarone) • S/E/Route: • Fatigue, tremors, sleep disturbances, numbness, ataxia, confusion, exertional dyspnea, non-productive cough, pleuritic chest pain, photosensitivity • s/e often cause clients to d/c use • > 400mg/day cause problems • Given oral or IV

  34. Amiodarone hydrochloride (Cordarone) • Nursing interventions: • Loading dose is needed • Watch monitor for new arrhythmias • Dose adjustment is difficult • Monitor/teach about post treatment arrhythmias • Wear sunscreen

  35. Class IV: Calcium (Ca+) channel blockers

  36. Class IV: Calcium (Ca+) channel blockers: Diltiazem (Cardizem) • Action/Use: • slows conduction through the AV node causing relaxation of the coronary and peripheral vessels • Dysrhythmias • S/E: • HA, dizziness, lower extremity edema, increases digoxin and quinidine levels

  37. Diltiazem (Cardizem) • Nursing interventions: • Do not crush or chew extended release tablets • Use with caution with other CV agents: digoxin, beta adrenergic blockers • Monitor for partial or complete heart block, heart failure

  38. Miscellaneous antidysrhythmics • Adenosine (Adenocard) • Digoxin (Lanoxin) • Ibutilide ( Corvert)

  39. Adenosine (Adenocard) • Action/Use: • Strong depressant effect on SA and AV nodes-slowing conduction • Treatment of paroxysmal supraventricular tachycardia (PST) • Physiologic roles: energy transfer, prostoglandin release, inhibits platelet aggregation, coronary vasodilation, suppresses heart rate

  40. Adenosine (Adenocard) • S/E • Flushing, SOB, chest pressure, nausea, HA, dizziness, peripheral edema, anxiety • Half life is 10 seconds—s/e are not lasting

  41. Objective 6: Describe nursing implications associated with antiarrhythmics • Give meds on scheduled time • Assess 6 cardinal signs of CV disease • Chest pain, dyspnea, edema, fatigue, syncope, palpitations (C-D-E-F-S-P) • Lab tests: CV markers (enzymes) • Physical assessment of client: include EKG readings

  42. Objective 6: Describe nursing implications associated with antiarrhythmics • Be prepared for emergency care • O2 as needed • Assist with ADLs • Client education • Lifestyle • Medications • Report s/e and adverse effects

  43. Objective 7: define essential hypertension • Also called ‘idiopathic’ • ‘essentially’ no known cause

  44. Objective 8: List the factors which determine Blood Pressure • Cardiac output • Increase cardiac output=increased BP • Peripheral vascular resistance (PVR) • Lumen inside vessels will constrict and dilate which determines PVR • Total Blood volume • (see diagram in Adams)

  45. Objective 9: Identify diuretics used as antihypertensives • Carbonic anhydrase inhibitors • Rarely used for hypertension • Thiazides • Loop diuretics • Potassium sparing • Used in combination therapy with thiazide or loop diuretic

  46. Diuretics: common actions/use • Deplete blood volume • Help excrete sodium • Dilate peripheral aterioles • Specific action unknown • Often used in combination • Potentiates activity of other antihypertensives • Cheap and effective

  47. Diuretics • Thiazides: • Most effective if creatinine clearance >30 • Most commonly used: Hydrochlorothiazide • Loop diuretics • Used when creatinine clearance <30 • Most commonly used Furosemide (Lasix)

  48. Diuretics • Potassium sparing • Contraindicated with renal disease, pregnancy, gout or kidney stones • Nursing interventions: • Monitor labs (WBC decrease, liver and kidney) • Client education • Most commonly used: Spirolactone (aldactone) • S/E: gynecomastia, testicular atrophy, hirsutism

More Related